LivaNova (LIVN) FCF Payout Ratio (2016 - 2017)
LivaNova recorded quarterly FCF Payout Ratio of 0.21 in Q1 2017, up 2108.62% quarter-over-quarter from 0.01 in Q4 2016, and down 89.3% year-over-year from 1.95 in Q1 2016.
LivaNova's FCF Payout Ratio history runs 2 years deep, the most recent figure standing at 0.21 for Q1 2017.
- In Q1 2017, FCF Payout Ratio fell 89.3% year-over-year to 0.21; the TTM figure through Mar 2017 stood at 0.13 (changed N/A YoY), while the FY2016 annual figure was 0.12, changed N/A from the prior year.
- FCF Payout Ratio came in at 0.21 for Q1 2017 at LivaNova, up from 0.01 in the prior quarter.
- In the past five years, FCF Payout Ratio ranged from a high of 1.95 in Q1 2016 to a low of 0.01 in Q4 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.20 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.81 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.40 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.08 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.25 |
| 10 | LivaNova | 4.03 Bn | 3.45 Bn | 243.75 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 0.21 |
| Dec 31, 2016 | -0.01 |
| Sep 30, 2016 | 0.12 |
| Mar 31, 2016 | 1.95 |